Author pages are created from data sourced from our academic publisher partnerships and public sources.
Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration.
- P. Theodossiadis, V. Liarakos, P. Sfikakis, I. Vergados, G. Theodossiadis
- American journal of ophthalmology
- 1 May 2009
PURPOSE To present our preliminary experience on intravitreal administration of an anti-tumor necrosis factor (TNF) monoclonal antibody for neovascular age-related macular degeneration (AMD). … Expand
Near complete visual recovery and refractive stability in modern corneal transplantation: Descemet membrane endothelial keratoplasty (DMEK).
- Korine van Dijk, L. Ham, +4 authors G. Melles
- Contact lens & anterior eye : the journal of the…
- 1 February 2013
OBJECTIVE To report the 6 months results of a large prospective study on Descemet membrane endothelial keratoplasty (DMEK) for management of corneal endothelial disorders. METHODS DMEK was… Expand
Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
- M. Papathanassiou, P. Theodossiadis, V. Liarakos, A. Rouvas, E. J. Giamarellos-Bourboulis, I. Vergados
- American journal of ophthalmology
- 1 March 2008
PURPOSE To evaluate the effect of subconjunctival injection of bevacizumab on experimentally induced corneal neovascularization. DESIGN Experimental animal study. METHODS Twelve New Zealand white… Expand
Endothelial keratoplasty for bullous keratopathy in eyes with an anterior chamber intraocular lens
- V. Liarakos, L. Ham, +4 authors G. Melles
- Journal of cataract and refractive surgery
- 1 December 2013
Purpose To describe how to approach eyes with phakic or pseudophakic bullous keratopathy that have an anterior chamber intraocular lens (AC IOL) using thin Descemet‐stripping endothelial keratoplasty… Expand
Multicenter study of descemet membrane endothelial keratoplasty: first case series of 18 surgeons.
IMPORTANCE Surgeons starting to perform Descemet membrane endothelial keratoplasty (DMEK) should be informed about the learning curve and experience of others. OBJECTIVE To document the clinical… Expand
Identifying causes for poor visual outcome after DSEK/DSAEK following secondary DMEK in the same eye
Purpose: To identify causes of reduced visual acuity after Descemet stripping (automated) endothelial keratoplasty (DSEK/DSAEK) and to determine whether such eyes can be successfully ‘repaired’ with… Expand
Management of canalicular obstructions
- V. Liarakos, K. Boboridis, E. Mavrikakis, I. Mavrikakis
- Current opinion in ophthalmology
- 1 September 2009
Purpose of review The successful treatment of canalicular obstructions continues to represent a therapeutic challenge. Conjuctivodacryocystorhinostomy with a Lester Jones bypass tube is the standard… Expand
Intravitreal administration of the anti-TNF monoclonal antibody Infliximab in the rabbit
- P. Theodossiadis, V. Liarakos, +4 authors I. Vergados
- Graefe's Archive for Clinical and Experimental…
- 1 February 2009
BackgroundTumor necrosis factor (TNF) is known to play an important role in various immune-mediated ocular diseases; intravenous administration of the anti-TNF monoclonal antibody infliximab has… Expand
The Effect of Intravitreal Ranibizumab on the Fellow Untreated Eye with Subfoveal Scarring due to Exudative Age-Related Macular Degeneration
Aim: Our purpose was to evaluate the possible effect of intravitreal ranibizumab on the fellow untreated eye with choroidal neovascularization (CNV) and subfoveal scarring associated with age-related… Expand
Descemet Membrane Endothelial Keratoplasty for a Decompensated Penetrating Keratoplasty Graft in the Presence of a Long Glaucoma Tube
Purpose: To describe specific maneuvers and technical modifications to the standardized “no-touch” technique of Descemet membrane endothelial keratoplasty (DMEK) to successfully handle the presence… Expand